| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 4 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | -0 | 0 | 0 | -0 | -0 | -0 | -4 | -0 | -0 | 0 | -0 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 0 | -4 | -0 | -0 | -0 | -4 | -0 | -0 | 0 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -0 | 0 | -4 | -0 | -0 | -0 | -4 | -0 | -0 | 0 | 1 |
| EPS in ₹ | -0.05 | -0.11 | 0.00 | -6.37 | -0.58 | -0.54 | -0.41 | -6.55 | -0.17 | -0.10 | 0.64 | 1.11 |
Bacil Pharma
Bacil Pharma
29.68
-1.56
(-4.99%)
Market Cap
42.56 Cr
PE Ratio
28.93
Volume
748.00
Day High - Low
29.68 - 29.68
52W High-Low
61.80 - 26.69
Key Fundamentals
Market Cap
42.56 Cr
EPS
1.11
PE Ratio
28.93
PB Ratio
1.78
Book Value
17.55
EBITDA
-0.25
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
1.59
Debt to Equity
0.01
Actual
Company News
View All News
Bacil Pharma's board approved a ₹50 Cr rights issue and increased authorised capital. Two independent directors resigned on July 9, 2026.
Bacil Pharma received approval for the name Bacil Research & Development Private Limited for its proposed wholly-owned subsidiary. The name is valid for 20 days until July 26, 2026.
Bacil Pharma board to meet on July 9
Jul 03, 2026
Jul 03, 2026Bacil Pharma's board will meet on July 9, 2026, to consider a rights issue worth up to ₹50 crore and fund raising proposals.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,954.00 | #1 4,68,830.05 | 40.50 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 63.70 | |
7,305.00 | 1,93,924.80 | 76.36 | 11,067.00 | 13.95 | 2,568 | 13.44 | 67.54 | |
5,065.20 | 1,92,663.93 | 89.58 | 13,886.20 | 20.34 | 2,138 | -26.91 | 67.43 | |
1,393.00 | 1,12,532.85 | 29.60 | 29,044.60 | 2.24 | 3,870 | -55.32 | 41.15 | |
1,113.80 | 1,12,074.34 | 22.00 | 27,657.90 | 17.64 | 5,026 | 7.82 | 47.79 | |
2,396.30 | 1,09,566.63 | #1 20.54 | 29,038.90 | #1 26.75 | 5,356 | #1 87.72 | 46.58 | |
2,557.40 | 1,05,619.59 | 54.21 | 14,636.40 | 14.85 | 1,938 | 31.75 | 57.20 | |
1,166.30 | 97,347.45 | 31.02 | 35,058.60 | 3.90 | 4,158 | -69.10 | 27.38 | |
1,523.40 | 87,653.07 | 25.42 | 33,384.70 | 3.21 | 3,376 | 1.99 | 47.69 | |
1,568.30 | 84,665.71 | 95.73 | 6,867.80 | 22.01 | 890 | 21.18 | 62.10 |
Growth Rate
Revenue Growth
-100.00 %
Net Income Growth
147.50 %
Cash Flow Change
0.40 %
ROE
-132.65 %
ROCE
-132.92 %
EBITDA Margin (Avg.)
-100.00 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 7 | 7 | 7 | 5 | 5 | 4 | 4 | 1 | 1 | 1 | 26 | 27 |
| Fixed Assets | 0 | 5 | 6 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 2 |
| Capital Work in Progress | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 21 | 0 |
| Other Assets | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 0 |
| Total Equity & Liabilities | 7 | 7 | 7 | 5 | 5 | 4 | 4 | 1 | 1 | 1 | 26 | 27 |
| Current Liabilities | 0 | 0 | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 3 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7 | 6 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 25 | 25 |
| Reserve & Surplus | -0 | -0 | -0 | -4 | -5 | -5 | -5 | -5 | -5 | -5 | 12 | 11 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 14 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 3 |
| Investing Activities | -0 | -0 | 0 | -1 | 0 | 0 | 1 | 4 | -0 | 0 | 0 |
| Operating Activities | 0 | 0 | 0 | 1 | -0 | -0 | -0 | -4 | -0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | -0 | 2 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 42.67 % | 20.70 % | 10.60 % | 0.20 % | 0.20 % | 0.08 % | 0.08 % | 0.08 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 51.38 % | 53.85 % | 53.88 % | 52.88 % | 52.83 % | 52.90 % | 53.74 % | 53.77 % | 53.76 % | 53.79 % | 53.80 % | 53.77 % | 53.89 % | 53.91 % | 59.61 % | 67.42 % | 75.77 % | 77.37 % | 79.74 % | 80.95 % | 80.95 % | 98.26 % | 95.77 % |
| Others | 5.95 % | 3.48 % | 3.45 % | 4.45 % | 4.50 % | 4.43 % | 3.59 % | 3.56 % | 3.57 % | 3.54 % | 3.53 % | 3.56 % | 3.44 % | 3.42 % | 19.69 % | 21.98 % | 24.03 % | 22.43 % | 20.18 % | 18.97 % | 18.97 % | 1.74 % | 4.23 % |
| No of Share Holders | 0 | 6,410 | 6,319 | 6,461 | 6,514 | 6,532 | 6,545 | 6,548 | 6,649 | 6,663 | 6,647 | 6,628 | 6,770 | 6,794 | 6,902 | 7,461 | 7,638 | 7,532 | 7,541 | 7,431 | 7,431 | 7,226 | 7,326 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 21.11 | 27.73 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 35.09 | 38.72 |
| 14 Nov 2024 |  Extraordinary General Meeting | NA | 14 Nov 2024 | 37.97 | 48.04 |
| 21 Jan 2025 | Quarterly Result Announcement | NA | 21 Jan 2025 | 46.26 | 42.55 |
| 26 May 2025 | Quarterly Result Announcement | NA | 26 May 2025 | 43.70 | 43.70 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 37.58 | 37.50 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 35.00 | 40.37 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 31.19 | 29.11 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 39.90 | 42.97 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 56.93 | 53.78 |
Announcements
Attached Resignation Of Directors As Query Raised From BSE5 days ago
5 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Change in ManagementJul 10, 2026
Jul 10, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJul 09, 2026
Jul 09, 2026Announcement under Regulation 30 (LODR)-Raising of FundsJul 09, 2026
Jul 09, 2026Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015Jul 09, 2026
Jul 09, 2026Intimation Regarding Approval Of Name For Proposed Wholly-Owned SubsidiaryJul 07, 2026
Jul 07, 2026Board Meeting Intimation for We Hereby Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Thursday 9Th July 2026Jul 03, 2026
Jul 03, 2026Intimation For Appointment Of Independent DirectorJun 30, 2026
Jun 30, 2026Withdrawal Of Intimation For Appointment Of Independent DirectorsJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateJun 29, 2026
Jun 29, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 29, 2026
Jun 29, 2026Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On 26Th June 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 26, 2026
Jun 26, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 25, 2026
Jun 25, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 24, 2026
Jun 24, 2026Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 23, 2026
Jun 23, 2026Intimation Of Proposed Incorporation Of Wholly-Owned SubsidiaryJun 18, 2026
Jun 18, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 13, 2026
Jun 13, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 11, 2026
Jun 11, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 05, 2026
Jun 05, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
May 28, 2026Company Has Not Entered Any Related Party Transactions During The Half Year Ended 31St March 2026.May 22, 2026
May 22, 2026Statement Of Deviation Or Variation In Utilization Of Funds Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Is Not Applicable To The Company For The Quarter Ended 31St March 2026.May 22, 2026
May 22, 2026Audited Financial Results For 31St March 2026May 22, 2026
May 22, 2026Board Meeting Outcome for Outcome Of Board Meeting For Audited Results For 31St March 2026May 22, 2026
May 22, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 22Nd May 2026May 11, 2026
May 11, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 27, 2026
Apr 27, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 27, 2026
Apr 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Clarification On Price MovementFeb 24, 2026
Feb 24, 2026Clarification sought from Bacil Pharma LtdFeb 24, 2026
Feb 24, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 23, 2026
Feb 23, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 23, 2026
Feb 23, 2026Revised Un-Audited Financial Result For 31St December 2025Feb 13, 2026
Feb 13, 2026Unaudited Financial Result For 31St December 2025Feb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026Feb 13, 2026
Feb 13, 2026Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday 13Th February 2026Feb 05, 2026
Feb 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 29, 2025
Dec 29, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 29, 2025
Dec 29, 2025Appointment of Company Secretary and Compliance OfficerDec 19, 2025
Dec 19, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 01, 2025
Dec 01, 2025Un-Audited Financial Result For 30Th September 2025Nov 13, 2025
Nov 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025Nov 13, 2025
Nov 13, 2025Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Thursday 13Th November 2025Nov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Oct 14, 2025Technical Indicators
RSI(14)
Neutral 20.40
ATR(14)
Less Volatile 2.66
STOCH(9,6)
Oversold 9.80
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.28
ADX(14)
Weak Trend 19.11
UO(9)
Bullish 29.67
ROC(12)
Downtrend And Accelerating -20.67
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
